Yahoo奇摩 網頁搜尋

搜尋結果

  1. LifeSphere MultiVigilance (前称ARISg/ARISc)—满足中国监管合规要求的药物警戒数据库. ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market.

  2. China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software.

  3. Tomorrow’s Intake Today. Achieve up to 65% efficiency gains with up to 90% accuracy with Gen AI-powered dynamic data extraction and advanced LLM-based narrative generation, complete with rapid deployment and seamless integration with any Safety system. Learn More.

    • 守宮1
    • 守宮2
    • 守宮3
    • 守宮4
    • 守宮5
  4. Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution. The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases. Learn More.

  5. This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.

  6. 2018年10月3日 · MIAMI, FL. October 3, 2018 – ArisGlobal, a leading life sciences technology provider, announced the launch of LifeSphere MultiVigilance – the next-generation platform for individual case safety report (ICSR) intake powered by LifeSphere Nava – ArisGlobal’s cognitive computing engine.

  7. 2017年6月6日 · AstraZeneca selects ArisGlobal LifeSphere® Signal and Risk Management. Next-Generation, Multi-Tenant Cloud Solution Offers Enhanced Capabilities for the Complete Management of Safety Signals for Improved Benefit-Risk Decisions.

  1. 其他人也搜尋了